Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet CLIVARIN -MULTI 5726UI / ml solution for injection
Precautions:
Major drug interactions
This medicine may have important interactions with other medicines.
Additional monitoring
This medicine is subject to additional monitoring.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Bleeding risk
This medicine may increase the risk of bleeding.
Reviparin is an anticoagulant from the low molecular weight heparin class, used for the prevention and treatment of deep vein thrombosis and pulmonary embolism. It works by inhibiting coagulation factors, reducing blood clot formation.
The medication is administered subcutaneously, as directed by a doctor, usually once or twice daily. It is important for patients to follow the treatment regimen and undergo regular blood tests to monitor coagulation.
Patients should be aware of potential side effects, such as bleeding, bruising, or injection site reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include bleeding, bruising, and injection site reactions. In rare cases, severe reactions such as heparin-induced thrombocytopenia or major bleeding may occur. Patients should be informed of these risks before use.
The medication is administered subcutaneously, as directed by a doctor, usually once or twice daily. It is important for patients to follow the treatment regimen and undergo regular blood tests to monitor coagulation.
Patients should be aware of potential side effects, such as bleeding, bruising, or injection site reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include bleeding, bruising, and injection site reactions. In rare cases, severe reactions such as heparin-induced thrombocytopenia or major bleeding may occur. Patients should be informed of these risks before use.
General data about CLIVARIN -MULTI 5726UI / ml
- Substance:
- reviparin
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W12808002
- Concentration:
- 5726UI / ml
- Pharmaceutical form:
- solution for injection
- Quantity:
- 5
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for reviparin
- 1432UI/0.25ml
- 3436UI/0.6ml
- 5726UI/ml